ImageneBio Inc (IMA) has a negative trailing P/E of -1.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -82.66%.
Criteria proven by this page:
Overall SharesGrow Score: 42/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -336.9 | 0.00 | -300.32 | 13,905.94 | - |
| 2019 | -818.6 | 13.93 | -223.99 | 1,001.01 | - |
| 2020 | -121.4 | -0.21 | -53.16 | 584.21 | - |
| 2021 | -158.7 | 2.27 | 26.04 | 174.71 | - |
| 2022 | -16.8 | -0.17 | 7.86 | 73.96 | - |
| 2023 | -14.5 | 1.02 | 5.81 | 107.71 | - |
| 2024 | -26.0 | 0.69 | 7.54 | 271.35 | - |
| 2025 | -0.7 | 0.00 | 0.25 | 42.01 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $-1.14 | $990K | $-40.87M | -4127.8% |
| 2019 | $-0.47 | $13.75M | $-16.82M | -122.3% |
| 2020 | $-3.16 | $9.19M | $-44.26M | -481.4% |
| 2021 | $-0.95 | $30.99M | $-34.12M | -110.1% |
| 2022 | $-1.90 | $15.62M | $-68.77M | -440.3% |
| 2023 | $-1.63 | $9.16M | $-68.17M | -744.2% |
| 2024 | $-1.02 | $3.5M | $-36.57M | -1044.8% |
| 2025 | $-10.76 | $800K | $-45.35M | -5668.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-2.93 | $-5.08 – $-1.21 | $340.24K | $340.24K – $340.24K | 2 |
| 2027 | $-2.41 | $-3.88 – $-0.57 | $144.71K | $144.71K – $144.71K | 2 |
| 2028 | $-3.19 | $-5.00 – $-0.75 | $61.54K | $61.54K – $61.54K | 3 |
| 2029 | $-3.64 | $-3.64 – $-3.64 | $26.18K | $26.18K – $26.18K | 1 |
| 2030 | $-3.41 | $-3.41 – $-3.41 | $20.5M | $20.5M – $20.5M | 1 |
